Your browser doesn't support javascript.
loading
Mendelian randomization for studying the effects of perturbing drug targets.
Gill, Dipender; Georgakis, Marios K; Walker, Venexia M; Schmidt, A Floriaan; Gkatzionis, Apostolos; Freitag, Daniel F; Finan, Chris; Hingorani, Aroon D; Howson, Joanna M M; Burgess, Stephen; Swerdlow, Daniel I; Davey Smith, George; Holmes, Michael V; Dichgans, Martin; Scott, Robert A; Zheng, Jie; Psaty, Bruce M; Davies, Neil M.
Afiliação
  • Gill D; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Georgakis MK; Centre for Pharmacology and Therapeutics, Department of Medicine, Imperial College London, London, UK.
  • Walker VM; Novo Nordisk Research Centre, Oxford, UK.
  • Schmidt AF; Clinical Pharmacology and Therapeutics Section, Institute of Medical and Biomedical Education and Institute for Infection and Immunity, St George's, University of London, London, UK.
  • Gkatzionis A; Clinical Pharmacology Group, Pharmacy and Medicines Directorate, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Freitag DF; Institute for Stroke and Dementia Research (ISD), University Hospital of Ludwig-Maximilians-University (LMU), Munich, Germany.
  • Finan C; Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Hingorani AD; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Howson JMM; Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Burgess S; Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, UK.
  • Swerdlow DI; Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Davey Smith G; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, UK.
  • Holmes MV; Bayer Pharmaceuticals, Open Innovation & Digital Technologies, Wuppertal, Germany.
  • Dichgans M; Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, UK.
  • Scott RA; UCL British Heart Foundation Research Acceleratorversity College London, London, UK.
  • Zheng J; UCL Hospitals, NIHR Biomedical Research Centre, London, UK.
  • Psaty BM; Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, UK.
  • Davies NM; UCL British Heart Foundation Research Acceleratorversity College London, London, UK.
Wellcome Open Res ; 6: 16, 2021.
Article em En | MEDLINE | ID: mdl-33644404
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Wellcome Open Res Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Wellcome Open Res Ano de publicação: 2021 Tipo de documento: Article